SUZHOU SIRNAOMICS BIOPHARMACEUTICALS CO LTD has a total of 12 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are OLOGY BIOSERVICES INC, CELL MED RES GMBH and EXOSTEMTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 8 | |
#2 | Canada | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Xu Jun | 6 |
#2 | Lu Yang | 6 |
#3 | Simonenko Vera | 5 |
#4 | Ansari Aslam | 5 |
#5 | Xu John J | 5 |
#6 | Zhong Tom | 5 |
#7 | Guan Parker J | 5 |
#8 | Lu Patrick Y | 5 |
#9 | Shenggao Tang | 2 |
#10 | Yang Lu | 2 |
Publication | Filing date | Title |
---|---|---|
CN110573166A | gemcitabine derivatives for cancer therapy | |
CN105363042A | Medicine composition and application thereof | |
CN105063044A | Active molecule capable of suppressing gene replication of Ebola virus and usage method thereof | |
CN104876831A | Liposome-modified spermine derivative and liposome prepared by derivative | |
CN103623425A | Medicament for inhibiting neovascularization diseases angiogenesis by using dual-target antagomir | |
CN103007291A | Composition for treating eye diseases by double-target/multi-target small nucleic acid and applications of composition | |
CN102031260A | Short interfering ribonucleic acid (siRNA) for promoting scarless healing of skin wounds and application thereof | |
CN101897982A | SiRNA medicinal composition for treating cancers |